Name | Number of supported studies | Average coverage | |
---|---|---|---|
enterocyte | 3 studies | 20% ± 4% |
Insufficient scRNA-seq data for expression of MOGAT3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 1065.43 | 226 / 226 | 82% | 26.72 | 332 / 406 |
intestine | 68% | 1006.35 | 653 / 966 | 81% | 24.82 | 428 / 527 |
kidney | 97% | 110.10 | 86 / 89 | 41% | 4.33 | 369 / 901 |
stomach | 3% | 0.76 | 9 / 359 | 72% | 21.67 | 205 / 286 |
esophagus | 1% | 0.86 | 10 / 1445 | 28% | 5.48 | 52 / 183 |
bladder | 0% | 0 | 0 / 21 | 23% | 6.25 | 114 / 504 |
pancreas | 0% | 0 | 0 / 328 | 19% | 2.08 | 34 / 178 |
lung | 0% | 0.08 | 1 / 578 | 8% | 1.22 | 95 / 1155 |
uterus | 1% | 0.48 | 2 / 170 | 2% | 0.49 | 8 / 459 |
breast | 2% | 4.50 | 7 / 459 | 0% | 0 | 0 / 1118 |
ovary | 1% | 0.15 | 1 / 180 | 1% | 0.06 | 4 / 430 |
peripheral blood | 1% | 0.36 | 8 / 929 | 0% | 0 | 0 / 0 |
adipose | 1% | 0.24 | 10 / 1204 | 0% | 0 | 0 / 0 |
spleen | 0% | 0.74 | 1 / 241 | 0% | 0 | 0 / 0 |
prostate | 0% | 0.18 | 1 / 245 | 0% | 0 | 0 / 502 |
brain | 0% | 0.07 | 10 / 2642 | 0% | 0 | 0 / 705 |
thymus | 0% | 0.03 | 1 / 653 | 0% | 0 | 0 / 605 |
blood vessel | 0% | 0.05 | 2 / 1335 | 0% | 0 | 0 / 0 |
heart | 0% | 0.02 | 1 / 861 | 0% | 0 | 0 / 0 |
skin | 0% | 0.02 | 2 / 1809 | 0% | 0 | 0 / 472 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0 | 0 / 258 | 0% | 0 | 0 / 230 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006071 | Biological process | glycerol metabolic process |
GO_0019432 | Biological process | triglyceride biosynthetic process |
GO_0006640 | Biological process | monoacylglycerol biosynthetic process |
GO_1990578 | Cellular component | perinuclear endoplasmic reticulum membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0003846 | Molecular function | 2-acylglycerol O-acyltransferase activity |
GO_0004144 | Molecular function | diacylglycerol O-acyltransferase activity |
Gene name | MOGAT3 |
Protein name | 2-acylglycerol O-acyltransferase 3 (EC 2.3.1.20) (EC 2.3.1.22) (Acyl-CoA:monoacylglycerol acyltransferase 3) (MGAT3) (Diacylglycerol O-acyltransferase candidate 7) (hDC7) (Diacylglycerol acyltransferase 2-like protein 7) (Monoacylglycerol O-acyltransferase 3) |
Synonyms | DC7 DGAT2L7 UNQ9383/PRO34208 |
Description | FUNCTION: Catalyzes the formation of diacylglycerol from 2-monoacylglycerol and fatty acyl-CoA. Also able to catalyze the terminal step in triacylglycerol synthesis by using diacylglycerol and fatty acyl-CoA as substrates. Has a preference toward palmitoyl-CoA and oleoyl-CoA. May be involved in absorption of dietary fat in the small intestine by catalyzing the resynthesis of triacylglycerol in enterocytes. Also able to use 1-monoalkylglycerol (1-MAkG) as an acyl acceptor for the synthesis of monoalkyl-monoacylglycerol (MAMAG) . . |
Accessions | ENST00000379423.3 [Q86VF5-2] ENST00000440203.6 [Q86VF5-3] ENST00000223114.9 [Q86VF5-1] Q86VF5 |